GlycaNova, the Norwegian biotechnology company focused on over-the-counter and prescription products for immune system disorders, is pleased to announce the launch of Ganodex(TM), its highly innovative, over-the-counter skin cream treatment for problems such as eczema and psoriasis. Ganodex(TM) has been developed by GlycaNova researchers over the past 4 years, using a proprietary extract from medicinal mushrooms as the active ingredient.

Initial trial results show that Ganodex(TM) has the ability to dramatically improve symptoms of psoriasis and eczema. Formulated as a skin cream, daily application to the affected skin stimulates and regulates skin cells, thereby improving the skin condition. Ganodex(TM) contains 100% natural ingredients. Common side effects, such as drying out of the skin often experienced with creams containing cortisone and parabens, have not been seen in patients using Ganodex(TM)

GlycaNova is pleased to announce Ganodex(TM) is now Bjorn Kristiansen, CEO of GlycaNova, commented: “We are delighted to be able to offer psoriasis and eczema sufferers a completely new and natural alternative to steroid-based treatments. Those who have used Ganodex have experienced such positive results that we are pleased to be able to launch the product online to give wider access to this highly effective treatment.”

For more information
www.ganodex.com